Pierce Brosnan on Pan Bahar

Pierce Brosnan said that he is unaware that the product has harmful ingredients. They only told him that the product is just a breath freshener and tooth whitener.

Read Full Article

Celator Pharmaceuticals Shares Soared on Tuesday After Successful Test

Celator Pharmaceuticals shares jumped more than 400% in Tuesday trading. Meanwhile, hedge fund manager Steve Cohen unvelied his 8.3% shares of the company.

Read Full Article

Forty Seven Inc Raised $75 Million to Develop Antibodies for Cancer

The Series A round was announced on Wednesday. The company has also licensed the rights for multiple immuno-oncology programs from Stanford University.

Read Full Article

Better, quicker, shorter cancer care eyed by Intel thru Collaborative Cancer Cloud

Intel Health executive Eric Dishman has to fight his Kidney Cancer for 23 years before it was treated. Now, Intel launched a network that would make cancer treatment plans in just 1 day by 2020.

Read Full Article

Geron sells last drug in pipeline to J&J unit

Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.

Read Full Article

Insurance, income, education tied to survival after lung cancer surgery

How long patients survive after surgery to remove lung cancer may depend on factors like insurance, income and education, according to a new study.

Read Full Article

AstraZeneca looks to EU decision for next cancer drug boost

AstraZeneca's cancer drug pipeline, already on a roll following promising clinical trial results, could get a further boost next week from a European green light for an experimental medicine against ovarian cancer.

Read Full Article

FDA approves Eisai drug for chemotherapy-associated nausea

The U.S. Food and Drug Administration said on Friday it has approved Japanese pharmaceutical company Eisai's drug Akynzeo to treat nausea and vomiting in patients undergoing chemotherapy for cancer.

Read Full Article

U.S. approval of Merck cancer immunotherapy expected soon

U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.

Read Full Article

AstraZeneca strikes deal with biotech firm Immunocore to develop cancer drug

AstraZeneca's MedImmune unit has partnered with Immunocore, a private British biotechnology company, to develop a cancer drug that would tap on the body's immune system, Reuters reported.

Read Full Article

ImmunGene Inc raises USD9 million in Series A round

USD9 million was raised in Series A funding round for ImmunGene Inc.

Read Full Article

immatics biotechnologies closes Series D funding round

immatics raises EUR34 million in its latest Series D round financing.

Read Full Article
1 2

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics